Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review by Comai, Giorgia et al.
[page 57]                                                  [Italian Journal of Medicine 2018; 12:929] [page 57]
Introduction
Extra-intestinal manifestations are rather common
in inflammatory bowel disease (both Crohn’s disease
and ulcerative colitis) with a reported prevalence that
ranges from 6% to 46% of patients.1 Renal and uro-
logical involvement has a prevalence of 4-23% and is
mainly represented by nephrolithiasis, urinary fistulas
and malignancies in particular renal cell carcinoma
commonly diagnosed at a younger age compared to
the general population.2-4 Parenchymal renal involve-
ment is a rare but serious extra-intestinal manifestation
that can affect both glomerular and tubulo-interstitial
compartment.5 The pathogenesis of kidney damage in
inflammatory bowel disease (IBD), as in other extra-
intestinal manifestation, has not been completely un-
derstood; the main hypotheses consider that it is
related to intestinal disease activity and dependent on
the same immunological mechanism or, alternatively,
as a result of systemic autoimmune deregulation.6
Moreover drug toxicity can be considered as a relevant
cause of kidney damage in IBD patients.7 The most
common glomerulonephritis are immunoglobulin
(Ig)A nephropathy, membranous glomerulonephritis,
focal segmental glomerulosclerosis and amyloidosis,
whereas the most common types of tubulointerstitial
nephritis are drug-related or not drug-related.3
Case Report
A 37-year-old man with a past history of severe
obesity [body mass index (BMI) >35] and mild hyper-
tension, successfully treated with β-blocker, a family
history positive for ulcerous colitis (father) and kidney
disease (cousin with end stage kidney disease for un-
known nephropathy), with a recent histological diag-
nosis of active ulcerative colitis established after 4
months of changing bowel habits, abdominal pain and
mild fever.
Patient had been referred to nephrology clinic by
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a gastroenterologist after the finding of progressive
worsening in renal function (serum creatinine baseline
1 year earlier was 0.8 mg/dL, 6 months after 1.6
mg/dL increased to 2.2 mg/dL at the moment of the
evaluation, estimated glomerular filtration rate (eGFR)
CKD-EPI 47 mL/min/1.73 m2) associated with micro-
hematuria and sub-nephrotic proteinuria (0.4 gr/day).
No 5-acetylsalycilic acid (ASA) was administered in
order to avoid confounding factors on renal picture.
Azathioprine (50 mg twice daily) was prescribed to
control intestinal symptoms.
Physical examination at the admission revealed a
blood pressure of 110/60 mmHg, heart rate of 76 bpm,
weight of 93 kg (BMI 29 kg/m2). Blood tests shown a
serum creatinine of 2.27 mg/dL, eGFR CKD-EPI 45
mL/min/1.73 m2, anemia (hemoglobin 12 g/dL), white
blood cells count count and C-reactive protein were
normal, serum electrolytes were in optimal range,
parathyroid hormone 51 pg/mL. Urinary abnormalities
have been confirmed, urine culture was negative.
Immunological tests such as antinuclear antibodies,
anti-neutrophil cytoplasmic antibodies, anti-double
stranded DNA antibodies, C3/C4 fragment of comple-
ment system, and rheumatoid factor were normal.
Abdomen ultrasound showed kidneys of normal
size and echogenicity, without structural abnormali-
ties. A kidney biopsy was performed.
In kidney biopsy, light microscopy demonstrated
intense and diffuse interstitial infiltration by inflam-
matory cells including lymphocytes and monocytes,
leukocyte infiltration of the tubular epithelium called
tubulitis and a small amount of tubular necrosis. There
were also a lot of interstitial granulomata with epithe-
lioid histiocytes and a few giant cells without caseous
necrosis. The glomeruli were normal. Immunofluores-
cence was negative for all serum tested, a nonspecific
granular positivity for C3 was present in some tubular
basement membranes. Electron microscopic showed
the presence of interstitial inflammatory infiltration of
lympho-monocytes also present in peritubular capil-
laries. The diagnosis was acute granulomatous inter-
stitial nephritis (Figure 1).
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Figure 1. Light microscopic of the kidney biopsy showing interstitial infiltration by inflammatory cells, a huge number
of granulomata with epithelioid histiocytes and a few giant cells without caseous necrosis. A) Hematoxylin and eosin










The diagnosis of extra-intestinal manifestation of
ulcerative colitis has been placed once other causes of
granulomatous interstitial nephritis were excluded:
quantiferon test for tuberculosis was negative; an-
giotensin converting enzyme serum levels, high-reso-
lution computed tomography of the lung and whole
body Fluorine-18 fluorodeoxyglucose positron emis-
sion tomography were performed in order to exclude
sarcoidosis.
Patient has been treated with high-dose intra-
venous methylprednisolone bolus (250 mg ×3) grad-
ually tapered to oral 32 mg of prednisone daily,
associated with azathioprine for the ulcerative colitis
treatment (50 mg/daily).
Blood tests performed after 1 month of therapy
shown significant improvement in renal function,
serum creatinine was 1.69 mg/dL (eGFR CKD-EPI 62
mL/min/1.73 m2) and complete regression of intestinal
symptoms; blood pressure is well controlled without
anti-hypertensive drugs.
Discussion and Conclusions
Acute granulomatous interstitial nephritis is con-
sidered an uncommon pathological finding in renal
biopsy (<1% of native renal biopsies) that has been
associated with various etiologies, of which drug hy-
persensitivities and sarcoidosis encompass the major-
ity of cases.8
Ulcerative colitis is a chronic inflammatory dis-
ease with localization in the colon and rectum. The
exact pathogenesis is not fully clarified but involves a
dysregulation of the gastrointestinal immune system
in patients with a genetic predisposition. Extraintesti-
nal manifestations are common (up to 40% of patients)
and they are associated with autoimmune mechanism.9
In our case we observed a progressive worsening
of renal function in a patient with a recent finding of
ulcerative colitis without an ongoing treatment with
mesalazine or other nephrotoxic drugs. Since our pa-
tient had not used any drugs, we could postulate that
the main pathogenetic mechanism of renal injury was
the disease activity of ulcerative colitis.
Parenchymal renal disease in IBD has been de-
scribed but granulomatous interstitial nephritis is con-
sidered extremely rare.
In current literature many case reports describe
renal involvement in patients affected by ulcerative
colitis but systematic epidemiological studies are lack-
ing. Ambruzs et al. published in 2013 the most com-
prehensive case series on histopathological findings
in IBD patients: they retrospectively review all native
kidney biopsy examined and of 33,713 patients, 83
where affected by inflammatory bowel disease; the
most frequent diagnosis was IgA nephropathy (24%),
followed by interstitial nephritis (19%), nephrosclero-
sis (12%), acute tubular injury (8%) and proliferative
glomerulonephritis (7%) equally distributed between
Crohn’s disease and ulcerative colitis. The interstitial
nephritis cases where classified as acute, granuloma-
tous and chronic; all granulomatous cases where re-
lated to exposure to 5-ASA.10
In literature most cases of tubulo-interstitial
nephritis (TIN) are linked to 5-aminosalycilate expo-
sure, nevertheless is not always possible to discern if
kidney damage originated from extra-renal manifes-
tations of bowel disease or drug-induced toxicity.7
Lately some case reports described patients with TIN
not related to drugs exposure11 or as primary manifes-
tation of bowel disease.10 Moreover, recent studies
showed that tubular damage is tensely related to dis-
ease activity rather than drugs and that TIN biopsy-
proven in patients with IBD and absent 5-ASA
exposure, progressed independently of the intestinal
disease activity.12,13
Recent promising studies have reported as the ex-
pression of some protein biomarkers, such as neu-
trophil gelatinase-associated lipocalin, a molecule
with multiple activities, including anti-inflammatory
and immunomodulatory effects, can provide informa-
tion able to early detect IBD activity such as possible
renal damage.14,15
In conclusion, granulomatous interstitial nephritis
is a rare extraintestinal manifestation of ulcerative co-
litis, which is potentially due to systemic immune dys-
regulation and T-cell activation that it could be treated
successfully with immunosuppression. We suggest
that kidney function should be monitored and a renal
biopsy should be considered for those patients with a
persistent increase in serum creatinine.
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